Phase
Condition
N/ATreatment
Synovasure® Comprehensive Infection Panel
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Samples included in the Synovasure R&D database from patients tested for PJI throughthe PJI Panel at CDL.
Exclusion
Exclusion Criteria:
From Synovasure Database
Samples not submitted to CDL for PJI testing
Samples submitted to CDL from Institutions not participating in this study
Samples designated as being from anatomical locations other than "left hip", "left knee", "right hip", "right knee
Samples without SF-Cx results
Samples without SF-CRP results
Samples without AD results
Samples without WBC results
Samples without %PMN results
Samples with RBCs ≥ 1 million
Samples not meeting A280 specification for integrity: Remove A280 < 0.342 andA280 > 1.19
Samples received more than four (4) days after aspiration
Patient age < 18 From Institutional Medical Record
Patient who did not undergo surgical interventions after PJI Panel Testing
Synovasure testing performed less than 6 weeks after index surgery
Evidence of sinus tract communicating with the joint
Samples aspirated from patients using a spacer at the time of aspiration
Study Design
Study Description
Connect with a study center
Rothman Orthopedic Institute
Philadelphia, Pennsylvania 19107
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.